Current Pharmaceutical Design

Editorial (Thematic Issue: Effective and Promising Treatments for Neurological Disorders and Cancer)
pp. 1979-1980(2)
Author: V. Uteshev, Victor

Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders
pp. 1981-1985(5)
Authors: A. Schroeder, Rachel; Wecker, Lynn; M. Philpot, Rex

Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends
pp. 1986-1997(12)
Author: V. Uteshev, Victor

Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists
pp. 1998-2003(6)
Authors: F. Young, Michael; Wecker, Lynn

Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases
pp. 2004-2014(11)
Authors: Fuenzalida, Marco; æ#129;ngel Pérez, Miguel; R. Arias, Hugo

Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer’s Disease: The Role of Protein-Protein Interactions in Current and Future Treatment
pp. 2015-2034(20)
Authors: Skøtt Thomsen, Morten; Tobias Andreasen, Jesper; Arvaniti, Maria; Anne Kohlmeier, Kristi

The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
pp. 2035-2049(15)
Authors: Skok, Maryna; Lykhmus, Olena

Promising Therapies for Alzheimer's Disease
pp. 2050-2056(7)
Authors: Confaloni, Annamaria; Tosto, Giuseppe; Tata, Ada

Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types
pp. 2057-2063(7)
Author: A. Pandya, Anshul

Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease
pp. 2064-2071(8)
Authors: Werner, Felix-Martin; Covenas, Rafael

Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma
pp. 2072-2082(11)
Authors: B.G. Huber, Kathleen; V. Uteshev, Victor; R. Pauly, James

The Cholinergic Potential, the Vagus Nerve and Challenges in Treatment of Traumatic Brain Injury
pp. 2083-2092(10)
Authors: V. Uteshev, Victor; Tenovuo, Olli; Gaidhani, Nikhil

Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
pp. 2093-2116(24)
Author: Nikiforuk, Agnieszka

Targeting Functional Biomarkers in Schizophrenia with Neuroimaging
pp. 2117-2123(7)
Authors: P. Wylie, Korey; Smucny, Jason; T. Legget, Kristina; R. Tregellas, Jason

The Cholinergic System: An Emerging Drug Target for Schizophrenia
pp. 2124-2133(10)
Authors: Gibbons, Andrew; Dean, Brian

The Recent Development of α7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases
pp. 2134-2151(18)
Authors: Beinat, Corinne; D. Banister, Samuel; Herrera, Marco; Kassiou, Michael

Cholinergic Targets in Lung Cancer
pp. 2152-2159(8)
Author: Spindel, Eliot

Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment
pp. 2160-2169(10)
Authors: Mucchietto, Vanessa; Crespi, Arianna; Fasoli, Francesca; Clementi, Francesco; Gotti, Cecilia

Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
pp. 2170-2177(8)
Author: Elena Sales, María

Neuroprotective Strategies in Glaucoma
pp. 2178-2192(15)
Authors: A. Gossman, Cynthia; Christie, John; K. Webster, Mark; M. Linn, David; L. Linn, Cindy